{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:40:02Z","timestamp":1758940802916,"version":"3.44.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cpcardiol.2023.101603","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T22:43:09Z","timestamp":1674168189000},"page":"101603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Implications of CRISPR-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases"],"prefix":"10.1016","volume":"48","author":[{"given":"Mohammad Ali","family":"Sheikh Beig Goharrizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Ghodsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Memarjafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101603_bib0001","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers","volume":"26","author":"Mars","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrg.2016.160","article-title":"Genetics of coronary artery disease: discovery, biology and clinical translation","volume":"18","author":"Khera","year":"2017","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0003","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/CIRCRESAHA.120.317415","article-title":"Genetic regulation of atherosclerosis-relevant phenotypes in human vascular smooth muscle cells","volume":"127","author":"Aherrahrou","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0004","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1161\/CIR.0000000000000606","article-title":"Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association","volume":"138","author":"Pierpont","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0005","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/ng.3970","article-title":"Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands","volume":"49","author":"Jin","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0006","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3627","article-title":"Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing","volume":"48","author":"Sifrim","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0007","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/j.jacc.2019.03.520","article-title":"Contribution of gene regulatory networks to heritability of coronary artery disease","volume":"73","author":"Zeng","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0008","unstructured":"Medicine NLo. MedlinePlus: National Institutes of Health (NIH). Available from: https:\/\/medlineplus.gov\/."},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/ATVBAHA.117.309326","article-title":"CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia","volume":"38","author":"Chadwick","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0010","unstructured":"Olivaes J, Markoski M. Could the CRISPR\/Cas9 system be applied to atherosclerosis? 2016."},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009285","article-title":"Genome-scale CRISPR screening for modifiers of cellular LDL uptake","volume":"17","author":"Emmer","year":"2021","journal-title":"PLos Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0012","doi-asserted-by":"crossref","first-page":"H1883","DOI":"10.1152\/ajpheart.00514.2007","article-title":"Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse","volume":"293","author":"Banerjee","year":"2007","journal-title":"Am J Physiol-Heart Circulat Physiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0013","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026344","article-title":"Cardiac cell lineages that form the heart","volume":"5","author":"Meilhac","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0014","first-page":"368","article-title":"Recounting cardiac cellular composition","volume":"118","author":"Zhou","year":"2016","journal-title":"Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fcvm.2018.00101","article-title":"Cardiomyocyte\u2014endothelial cell interactions in cardiac remodeling and regeneration","volume":"5","author":"Talman","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0016","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.3390\/ijms21176388","article-title":"Human cell modeling for cardiovascular diseases","volume":"21","author":"Lippi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0017","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.10.028","article-title":"Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart","volume":"127","author":"Wu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0018","doi-asserted-by":"crossref","unstructured":"Nsair A, Schenke-Layland K, Van Handel B, et al. Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. 2012.","DOI":"10.1371\/annotation\/649fb8ef-a4c7-4ee7-b382-e1657b9aa07e"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0019","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/cvr\/cvz250","article-title":"CRISPR\/Cas9 gene-editing strategies in cardiovascular cells","volume":"116","author":"Vermersch","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0947-5","article-title":"The march of pluripotent stem cells in cardiovascular regenerative medicine","volume":"9","author":"Abou-Saleh","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0022","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0023","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1101\/gad.300400.117","article-title":"Id genes are essential for early heart formation","volume":"31","author":"Cunningham","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fgene.2020.00777","article-title":"Integrative analysis revealing human heart-specific genes and consolidating heart-related phenotypes","volume":"11","author":"Ahn","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0025","doi-asserted-by":"crossref","first-page":"e55730","DOI":"10.7554\/eLife.55730","article-title":"Arany Z. Cardiac endothelial cells maintain open chromatin and expression of cardiomyocyte myofibrillar genes","volume":"9","author":"Yucel","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0026","series-title":"Diseases of Swine","article-title":"Cardiovascular and Hematopoietic Systems","author":"Robinson","year":"2019"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0027","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cels.2021.05.001","article-title":"Cell states beyond transcriptomics: integrating structural organization and gene expression in hiPSC-derived cardiomyocytes","volume":"12","author":"Gerbin","year":"2021","journal-title":"Cell Syst"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0028","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cvr\/cvz257","article-title":"Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block","volume":"116","author":"Suryawanshi","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addr.2020.02.003","article-title":"Therapeutic genome editing in cardiovascular diseases","volume":"168","author":"Nishiga","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0030","unstructured":"Zhongming Z, Linong L, Wangqiang Z, Wei L. CRISPR injected into the blood treats a genetic disease for first time. 2021."},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110196","article-title":"Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA","volume":"38","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCRESAHA.118.312676","article-title":"At the heart of genome editing and cardiovascular diseases","volume":"123","author":"Hernandez-Benitez","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8960236","article-title":"The impact of CRISPR\/Cas9 technology on cardiac research: from disease modelling to therapeutic approaches","volume":"2017","author":"Motta","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0034","first-page":"67","article-title":"How genome editing could be used in the treatment of cardiovascular diseases","volume":"15","author":"Musunuru","year":"2018","journal-title":"Future Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0035","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/d41586-018-02482-4","article-title":"A CRISPR edit for heart disease","volume":"555","author":"King","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0036","first-page":"81","article-title":"The CRISPR\/Cas9 system and the possibility of genomic edition for cardiology","volume":"108","author":"Arend","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0037","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0102-76382010000300006","article-title":"VEGF gene therapy for angiogenesis in refractory angina: phase I\/II clinical trial","volume":"25","author":"Kalil","year":"2010","journal-title":"Brazil J Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jmcb\/mjt047","article-title":"Effective gene targeting in rabbits using RNA-guided Cas9 nucleases","volume":"6","author":"Yang","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0039","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fcell.2019.00239","article-title":"CRISPR Cas9 in pancreatic cancer research","volume":"7","author":"Yang","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0041","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0042","doi-asserted-by":"crossref","unstructured":"Redman M, King A, Watson C, King D. What is CRISPR\/Cas9? archives of disease in childhood-education and practice. 2016;101:213-5.","DOI":"10.1136\/archdischild-2016-310459"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0043","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/bs.pmbts.2020.12.012","article-title":"History, evolution and classification of CRISPR-Cas associated systems","volume":"179","author":"Agarwal","year":"2021","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0044","first-page":"33","article-title":"The CRISPR-Cas9 tool of gene editing: cheaper, faster, riskier","volume":"26","author":"Furrow","year":"2017","journal-title":"Ann Health L"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nmeth.2649","article-title":"Cas9 as a versatile tool for engineering biology","volume":"10","author":"Mali","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0046","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004832117","article-title":"Frequent loss of heterozygosity inCRISPR-Cas9\u2013edited early human embryos","volume":"118","author":"Alanis-Lobato","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0047","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro3569","article-title":"An updated evolutionary classification of CRISPR\u2013Cas systems","volume":"13","author":"Makarova","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0048","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tig.2018.05.004","article-title":"Gene editing on center stage","volume":"34","author":"Bak","year":"2018","journal-title":"Trends Genet"},{"issue":"R1","key":"10.1016\/j.cpcardiol.2023.101603_bib0049","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00299-021-02703-7","article-title":"CRISPR innovations in plant breeding","volume":"40","author":"Kim","year":"2021","journal-title":"Plant Cell Rep"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0051","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0052","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0053","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1474-4422(20)30368-9","article-title":"Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study","volume":"20","author":"Adams","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0054","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1566524016666160316150847","article-title":"The impact of CRISPR\/Cas9-based genomic engineering on biomedical research and medicine","volume":"16","author":"Go","year":"2016","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0056","first-page":"6","article-title":"Development of genetically modified Chinese hamster ovary host cells for the enhancement of recombinant tissue plasminogen activator expression. The Malaysian journal of medical sciences","volume":"23","author":"Rahimpour","year":"2016","journal-title":"MJMS"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0057","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03630269.2013.805418","article-title":"Utility of the multivariate approach in predicting \u03b2-thalassemia intermedia or \u03b2-thalassemia major types in Iranian patients","volume":"37","author":"Banan","year":"2013","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0058","article-title":"The potential of CRISPR-Cas9 for treating genetic disorders","volume":"9","author":"Lockyer","year":"2016","journal-title":"Biosci Horizons: Intl J Student Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0059","first-page":"1","article-title":"Sequence features associated with the cleavage efficiency of CRISPR\/Cas9 system","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0060","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkv575","article-title":"Cas9-chromatin binding information enables more accurate CRISPR off-target prediction","volume":"43","author":"Singh","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0061","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target effects in CRISPR\/Cas9-mediated genome engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Molecul Ther-Nucl Acids"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0062","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0063","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0064","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1073\/pnas.1407473111","article-title":"Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5\u039432 mutation confers resistance to HIV infection","volume":"111","author":"Ye","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0066","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0067","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0068","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9\u2013crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0069","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3389\/fcimb.2020.619763","article-title":"The CRISPR-Cas Mechanism for adaptive immunity and alternate bacterial functions fuels diverse biotechnologies","volume":"10","author":"Newsom","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0071","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.molcel.2018.01.032","article-title":"CRISPR RNA-dependent binding and cleavage of endogenous RNAs by the Campylobacter jejuni Cas9","volume":"69","author":"Dugar","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0072","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0073","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4161\/rna.24321","article-title":"The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems","volume":"10","author":"Chylinski","year":"2013","journal-title":"RNA Biol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0074","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0075","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0076","article-title":"CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences","volume":"10","author":"Prykhozhij","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0077","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0078","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/270805","article-title":"A guide RNA sequence design platform for the CRISPR\/Cas9 system for model organism genomes","volume":"2013","author":"Ma","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0079","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/742482","article-title":"SSFinder: high throughput CRISPR-Cas target sites prediction tool","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124633","article-title":"CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool","volume":"10","author":"Stemmer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0081","doi-asserted-by":"crossref","first-page":"W401","DOI":"10.1093\/nar\/gku410","article-title":"CHOPCHOP: a CRISPR\/Cas9 and TALEN web tool for genome editing","volume":"42","author":"Montague","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0082","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"suppl_2","key":"10.1016\/j.cpcardiol.2023.101603_bib0083","doi-asserted-by":"crossref","first-page":"W462","DOI":"10.1093\/nar\/gkq319","article-title":"ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool","volume":"38","author":"Sander","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0084","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/bioinformatics\/btu354","article-title":"GT-Scan: identifying unique genomic targets","volume":"30","author":"O'Brien","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/jib-2015-283","article-title":"Online high-throughput mutagenesis designer using scoring matrix of sequence-specific endonucleases","volume":"12","author":"Guo","year":"2015","journal-title":"J Integrat Bioinform (JIB)"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0086","article-title":"CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0087","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nmeth.2812","article-title":"E-CRISP: fast CRISPR target site identification","volume":"11","author":"Heigwer","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0088","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0496","article-title":"CRISPR-Cas: biology, mechanisms and relevance","volume":"371","author":"Hille","year":"2016","journal-title":"Philos trans R Soc B: biol Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0089","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Sander","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0090","unstructured":"Wikipedia. CRISPR. 2021."},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0091","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature13579","article-title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease","volume":"513","author":"Anders","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0092","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/mic.0.023960-0","article-title":"Short motif sequences determine the targets of the prokaryotic CRISPR defence system","volume":"155","author":"Mojica","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0093","series-title":"Genome Engineering via CRISPR-Cas9 System","first-page":"15","article-title":"Chapter 2 - Evolution and molecular mechanism of CRISPR\/Cas9 systems","author":"Bhushan","year":"2020"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.619763","article-title":"The CRISPR-Cas mechanism for adaptive immunity and alternate bacterial functions fuels diverse biotechnologies","volume":"10","author":"Newsom","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0096","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0097","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.jacc.2017.10.002","article-title":"Genome editing: the recent history and perspective in cardiovascular diseases","volume":"70","author":"Musunuru","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0098","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/stem.3110","article-title":"Inherited cardiac diseases, pluripotent stem cells, and genome editing combined\u2014the past, present, and future","volume":"38","author":"van den Brink","year":"2020","journal-title":"Stem Cells"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0099","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrcardio.2016.139","article-title":"Genome editing in cardiovascular diseases","volume":"14","author":"Strong","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molmed.2019.06.008","article-title":"CRISPR craze to transform cardiac biology","volume":"25","author":"van Kampen","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0101","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3345\/cep.2020.02096","article-title":"Application of CRISPR-Cas9 gene editing for congenital heart disease","volume":"64","author":"Seok","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2016.11.177","article-title":"The potential application and challenge of powerful CRISPR\/Cas9 system in cardiovascular research","volume":"227","author":"Li","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0103","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025030118","article-title":"Hypertrophic cardiomyopathy \u03b2-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state","volume":"118","author":"Vander Roest","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-1013-8","article-title":"Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR\/Cas9 gene editing system","volume":"18","author":"Yuan","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/nsr\/nwz013","article-title":"Genome editing in large animals: current status and future prospects","volume":"6","author":"Zhao","year":"2019","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0106","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1161\/ATVBAHA.119.312579","article-title":"Functional genomics and CRISPR applied to cardiovascular research and medicine","volume":"39","author":"Li","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06420","article-title":"An efficient genotyping method for genome-modified animals and human cells generated with CRISPR\/Cas9 system","volume":"4","author":"Zhu","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0108","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022 T to G\u2022 C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0109","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","article-title":"In Vivo AAV-CRISPR\/Cas9\u2013mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia","volume":"141","author":"Zhao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0111","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.3390\/ijms22168422","article-title":"Harnessing the potential of CRISPR\/Cas in atherosclerosis: disease modeling and therapeutic applications","volume":"22","author":"Siew","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0112","first-page":"1","article-title":"Gene editing in rabbits: unique opportunities for translational biomedical research","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.cpcardiol.2023.101603_bib0113","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MOL.0000000000000591","article-title":"CRISPR: a promising tool for lipid physiology and therapeutics","volume":"30","author":"Furgurson","year":"2019","journal-title":"Curr Opin Lipidol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:13:42Z","timestamp":1758939222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0146280623000208"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101603","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of CRISPR-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101603"}}